Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Analytical Chemistry

House Panel Moves Biodefense Bill

by Glenn Hess
August 8, 2011 | A version of this story appeared in Volume 89, Issue 32

The House of Representatives Energy & Commerce Committee has endorsed legislation that would reauthorize and fine-tune a 2006 law aimed at making sure the federal government is prepared to respond to a biological, chemical, radioactive, or nuclear terrorist attack. Specifically, H.R. 2405 is intended to renew the Biomedical Advanced Research & Development Authority and Project BioShield. The programs, overseen by the Health & Human Services Department, provide funding to promote development and stockpiling of vaccines and other medical countermeasures for anthrax, smallpox, and other threats. Rep. Mike J. Rogers (R-Mich.), the bill’s sponsor, says the legislation is particularly important as the 10th anniversary of the Sept. 11, 2001, terrorist attacks approaches. “Bioterrorism still represents a real threat to this country,” Rogers noted at a committee hearing last month. “Simply put, we must always be prepared.” The bill now heads to the House floor. Meanwhile, the Senate Health, Education, Labor & Pensions Committee is drafting similar legislation.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.